多组件方法来减少重症监护中的多药物耐药生物:确定理想战略
Salma AlBahrani1,2, Mustafa Saad3,4, Jaber S Alqahtani5
1Infectious Disease Unit, Specialty Internal Medicine, King Fahd Military Medical Complex, Dhahran, Saudi Arabia.
一个多组件的感染预防策略显著减少了重症监护病房的多重耐药生物 (MDROs). 这种方法结合了屏障保护,素浴,监测和员工参与,为打击抗菌素耐药性 (AMR) 提供了实际的解决方案.
科学领域:
- 与医疗保健相关的感染
- 预防和控制感染.
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 感染预防和控制 (IPC) 在急症医院至关重要,但其对抗多药耐药生物体 (MDROs) 的有效性需要进一步的基于证据的实践.
- 没有任何单一的干预措施在减少MDROs方面被证明是普遍有效的.
- 全球抗菌素耐药性 (AMR) 的上升需要有效的策略来管理重症监护机构的MDRO.
研究的目的:
- 审查关于减少重症监护单位MDROs的多元组件方法的关键发现.
- 突出IPC对MDROs的基于证据的实践的需要.
- 在增加AMR的背景下,应对MDRO的挑战.
主要方法:
- 关于减少MDRO的多元干预策略的现有文献的审查.
- 专注于在重症监护病房实施的干预措施.
- 综合方法的分析,包括屏障保护,素浴,微生物监测和员工参与.
主要成果:
- 多组件干预显著降低了患者环境被MDROs污染的可能性.
- 综合策略在单一方法失败的情况下表现出有效性.
- 关键组成部分包括加强屏障保护,素浴,微生物监测和工作人员积极参与.
结论:
- 多组件干预措施有效地减少了重症监护单位的MDROs.
- 基于实证的实用战略对于管理MDRO和制AMR至关重要.
- 持续开发和实施全面的IPC计划至关重要.
更多相关视频
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
12:03Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
相关概念视频
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Multicompartment Models: Overview
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
